A5360 (MINMON): A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to Populations Living with HCV Who Are HCV Treatment Naïve with Evidence of Active HCV Infection
October 20, 2021
Study Results
To see study results from A5360 click here.